EAACI Congress 2025
BackL-TPS18 - Allergen immunotherapy 08
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
D3.202
Allergen-Specific Immunotherapy Is Still Rarely Used: Results of an Online Survey in Lithuania
D3.196
Efficacy of sublingual immunotherapy in children with allergic rhinitis
D3.204
Elevated Tryptase Levels in a Severe Asthmatic Patient Undergoing SCIT for Birch: Implications for Monitoring and Personalized Treatment
D3.198
Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy
D3.193
Impact of subcutaneous allergen immunotherapy on autoimmune disease development or exacerbations: a cross-sectional study
D3.195
Reasons for declining venom immunotherapy and its burden on patients' daily lives
D3.194
Renewal’s analysis of liquid sublingual immunotherapy (SLIT) treatments using iPUMP: SPEED study, a Real-Life study
D3.197
When is molecular testing necessary? Rethinking allergy diagnostics for Dermatophagoides pteronyssinus
D3.203
Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts
